Blog
RSS FeedPosted by Michael Wonder on 05 Jun 2019
NHS publishes update on the use of biosimilars
5 June 2019 - The United Kingdom’s National Health Service (NHS) has published a new document for clinical and nonclinical ...
Posted by Michael Wonder on 05 Jun 2019
Could the NHS be part of a US-UK trade deal?
5 June 2019 - Donald Trump sparked concern about the health service’s future but the reality is more complex. ...
Posted by Michael Wonder on 05 Jun 2019
Families create buyers club for cut-price cystic fibrosis drug
5 June 2019 - Stalemate in NHS talks over Orkambi leads parents to buy generic version from Argentina. ...
Posted by Michael Wonder on 05 Jun 2019
Trump says UK’s National Health Service not on table in trade talks
5 June 2019 - ‘When you’re dealing in trade everything’s on the table, so NHS or anything else,’ US president said ...
Posted by Michael Wonder on 04 Jun 2019
US takes aim at the UK’s National Health Service
4 June 2019 - There are fears a US-UK trade deal could open the NHS up for privatisation and raise ...
Posted by Michael Wonder on 03 Jun 2019
Hancock says “NHS not for sale” in post-Brexit US trade talks
3 June 2019 - Tensions rise as President Trump arrives for state visit. ...
Posted by Michael Wonder on 30 May 2019
NICE backs Merck's Prevymis for CMV
30 May 2019 - NICE has published its final appraisal document for the use of Merck's Prevymis (letermovir/ID1153) in preventing ...
Posted by Michael Wonder on 28 May 2019
UK refuses to back 'game-changing' resolution on drug pricing
28 May 2019 - Global agreement urges governments to share information on actual cost of medicines, with aim of making them ...
Posted by Michael Wonder on 27 May 2019
NHS England wants money back guarantee on Orkambi
24 May 2019 - Vertex resisting real-world data proposal. ...
Posted by Michael Wonder on 26 May 2019
Calls for 'life changing' drug Aimovig on NHS in England
24 May 2019 - People who suffer from chronic migraines are calling for a new drug to be offered on ...
Posted by Michael Wonder on 24 May 2019
Final NICE guidance issued for Akcea’s Tegsedi
24 May 2019 - Akcea Therapeutics UK has announced that NICE has published a final guideline for its nerve damage ...
Posted by Michael Wonder on 21 May 2019
The global battle over high drug prices
21 May 2019 - Western countries, as well as poor ones, are demanding transparency in the cost of drugs. ...
Posted by Michael Wonder on 20 May 2019
Theresa May urges US makers of cystic fibrosis drug to strike ‘crucial’ deal with NHS
17 May 2019 - Theresa May last night urged US makers of a drug that prolongs life for cystic fibrosis sufferers ...
Posted by Michael Wonder on 18 May 2019
NICE recommends Revlimid as multiple myeloma alternative
17 May 2019 - NICE has recommended Revlimid (lenalidomide), a drug that helps to support the immune system to fight ...
Posted by Michael Wonder on 16 May 2019
Mum delivers 65 roses to Downing Street in bid to speed up NHS availability of vital cystic fibrosis drugs
16 May 2019 - Calls for NHS access to potentially life-saving drugs are growing, one year to the day after ...